Brain tumor drug receives designations from FDA
The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation for diffuse intrinsic pontine glioma and Orphan Drug Designation for treatment of malignant gli…
The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation for diffuse intrinsic pontine glioma and Orphan Drug Designation for treatment of malignant gli…